Please login to the form below
McKinsey
This page shows the latest McKinsey news and features for those working in and with pharma, biotech and healthcare.
Keeping it in the family pays dividends
It is clear the benefits leach into culture as a McKinsey survey of businesses owned by families and founders showed that 90% of board members said that family values were present
Latest news
-
I, Robot: How AI is redefining the use of data in healthcare
McKinsey's analysis of this space has recently suggested that the use of data handling strategies for pharmaceutical research could create up to $100bn in cost savings per year, and that
-
A new era of collaboration
A study by McKinsey found that if spending on health increases at the current rate, it will reach 50% of the GDP in most Organisation for Economic Cooperation and Development (OECD)
-
The Digital Patient
A 2014 survey from McKinsey &Co showed that three quarters of consumers in the UK, Germany and Singapore would like to make use of digital healthcare services – contrary to the perceived ... The McKinsey survey also exploded the myth that only younger
-
Novo Nordisk will work with IBM on diabetes care
hold the key to revolutionising R&D and accelerating productivity - as laid out in a McKinsey &Co report published in 2013.
-
Teva takes controlling stake in genomics specialist
A 2013 report on personalised medicine by McKinsey &Co acknowledged the "tremendous potential" for this type of approach in CNS diseases whilst noting it is still in its infancy.
More from news
Approximately 0 fully matching, plus 27 partially matching documents found.
Latest Intelligence
-
Pharma funding and M&A in 2020
Indeed, McKinsey research found that between 2001 and 2016, the share of revenues coming from innovations outside Big Pharma grew from 25% to almost 50%.
-
Mapping the patient journey and minding the gap
Speaking to McKinsey in 2016, the biotech CEO argued that a new generation of patient engagement was dawning.
-
It started with a miss
The facts tell a different story. Seven years after McKinsey’s much- quoted claim that around two-thirds of all new drugs fail to meet pre-launch sales expectations in their ... McKinsey agrees, claiming 75% of launches that underperform against
-
25 Women Leaders in UK Healthcare
Originally trained as a doctor, Sam practised medicine in her native Australia, South Africa and the UK before joining McKinsey and eventually specialising in healthcare. ... After McKinsey she moved into the NHS as a senior manager at a large teaching
-
The rise of digital comms
experience. Independents overtake relationship seekers. Traditionally, pharma companies targeted HCPs that were relationship seekers, as defined by McKinsey.
More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.
Latest appointments
-
BMS appoints Saurabh Saha as senior VP, global head of translational medicine
His other roles include consultant at McKinsey and Company and director and head of the new indications discovery unit at Novartis.
-
Sandoz UK promotes Tim de Gavre to country head
Prior that that he worked at McKinsey &Company and brings almost 20 years of healthcare, consulting and marketing experience to the firm.
-
Targovax appoints chief financial officer
He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey &Company's pharma and healthcare practice.
-
Nouscom appoints COO and board members
Prior to this, she was the global head of neurodegeneration at Novartis, and worked in the healthcare sector of McKinsey &Company in Chicago.
-
The Medicines Company appoints Biogen's Tony Kingsley
Kingsley also previously worked as a partner at McKinsey &Company focusing on the biotechnology, pharmaceutical and medical device industries.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications. The healthcare landscape has experienced a significant transformation in the past two decades. The advancement in digital health technology, the availability of ‘big data’ and a focus on a
-
Onyx Health Launch ‘Game-changing’ New Digital Offer
Research conducted by McKinsey and Company suggests that the pharma and healthcare sectors have a digital maturity score of just 27, lagging well behind other tightly regulated sectors such as insurance
-
What Pharma can learn from B2B digital trends
Following a survey from McKinsey, research has demonstrated that the fastest-growing B2B companies use digital and inside sales channels more effectively than slower-growing companies. ... McKinsey continues that this modern approach to B2B sales is
-
Unlocking potential: How can pharma capitalise on its resources to support the NHS?
However, a recent report from McKinsey &Company suggests that biopharma must do more to harness the power of digital channels in order to provide the kind of targeted, personalised digital communications ... Harnessing pharma’s rich educational assets.
-
Digital trends in B2B sales - how far behind is Pharma?
Following a survey from McKinsey, research has demonstrated that the fastest-growing B2B companies use digital and inside sales channels more effectively than slower-growing companies. ... McKinsey continues that this modern approach to B2B sales is
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- New study identifies drugs that are safe to use in COVID-19 treatment
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Novartis builds its case for novel MS treatment ofatumumab
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- OPEN Health at the World Orphan Drug Conference USA
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Quick links
Infographics
